The fact that the ghrelin-system, particularly its In1-ghrelin variant, was strongly altered in PCa supports the idea that this system could contribute to PCa tumorigenesis, and may provide novel tools to explore diagnostic/therapeutic-targets in this pathology. This evidence concerns the gene GHRL and posterior cortical atrophy.